Self-Monitoring Inr And Self-Managing Warfarin To Reduce Thromboembolic Events

A recent study published in the Lancet reports a 50% reduction in thromboembolic events among patients who self-monitor their INR and self-manage their warfarin dosing. Why aren’t these practices more common?